Literature DB >> 9723667

Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis.

M Kimura1, S Tsuruta, T Yoshida.   

Abstract

Although the level of house dust mite (HDM)-specific lymphocyte proliferation is high in infants with atopic dermatitis (AD), the level of HDM-specific IgE antibody (HDM-IgE-RAST) is usually very low or negative. To elucidate the cause of the deficient HDM-specific IgE antibody formation in infants with AD, we examined the profile of IL-4 and IFN-gamma production by HDM-stimulated PBMCs. The amount of IL-4 production was higher in infants with AD and in children with AD (3 to 15 years) than in the nonatopic control subjects. Although the amount of IFN-gamma production in children with AD was lower than that found in nonatopic children, it was higher in infants with AD than in nonatopic infants. This result suggests that HDM-specific helper T lymphocytes in infants with AD have not yet differentiated into TH2 but rather stayed at the stage of TH0. The level of IgE-RAST for egg white (EW) is already elevated in infants with AD. The amount of IL-4 produced by EW-stimulated PBMCs was comparable to that produced by HDM-stimulated PBMCs in infants with AD. However, the amount of IFN-gamma produced by EW-stimulated PBMCs was distinctly lower than that produced by HDM-stimulated PBMCs in infants with AD. Although there was no correlation between the amount of IL-4 production by HDM-stimulated PBMCs and the level of HDM-IgE-RAST in infants with AD, the amount of IL-4 production by EW-stimulated PBMCs was closely correlated with the level of EW-IgE-RAST. These results suggest that it is not the lack of IL-4 but rather a relative increase in IFN-gamma production by HDM-specific helper T lymphocytes that causes the deficiency of HDM-specific IgE-antibody synthesis in infants with AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723667     DOI: 10.1016/s0091-6749(98)70092-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Relationship between maternal and child cytokine responses to allergen and phytohaemagglutinin 2 years after delivery.

Authors:  A-K Larsson; C Nilsson; A Höglind; E Sverremark-Ekström; G Lilja; M Troye-Blomberg
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Differences in cytokine production by peripheral blood mononuclear cells (PBMC) between patients with atopic dermatitis and bronchial asthma.

Authors:  M Kimura; S Tsuruta; T Yoshida
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  DNA methylation and the expression of IL-4 and IFN-gamma promoter genes in patients with bronchial asthma.

Authors:  Nam-Hee Kwon; Jin-Seuk Kim; Jin-Young Lee; Mi-Jung Oh; Dong-Chull Choi
Journal:  J Clin Immunol       Date:  2007-11-14       Impact factor: 8.317

4.  Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma.

Authors:  Ji A Jung; Hirohito Kita; Barbara P Yawn; Thomas G Boyce; Kwang H Yoo; Michaela E McGree; Amy L Weaver; Peter Wollan; Robert M Jacobson; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

5.  Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.

Authors:  Changwei Li; Isabelle Maillet; Claire Mackowiak; Camille Viala; Franco Di Padova; Mei Li; Dieudonnée Togbe; Valérie Quesniaux; Yuping Lai; Bernhard Ryffel
Journal:  Cell Death Dis       Date:  2017-04-06       Impact factor: 8.469

6.  Synergistic effect of various regulatory factors in TH1/TH2 balance; immunotherapeutic approaches in asthma.

Authors:  Young-Cheol Lee
Journal:  Int J Biomed Sci       Date:  2008-03

7.  Local and systemic immunological parameters associated with remission of asthma symptoms in children.

Authors:  Susan Waserman; Parameswaran Nair; Denis Snider; Mary Conway; Lata Jayaram; Lynn M McCleary; Jerry Dolovich; Frederick E Hargreave; Jean S Marshall
Journal:  Allergy Asthma Clin Immunol       Date:  2012-10-08       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.